StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.07+0.57 (+4.56%)

Close on Nov 18, 2026Market cap $142.28MP/E –Yield –

Burning Rock Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Burning Rock Biotech

Burning Rock Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Burning Rock Biotech figures

See a number that looks wrong?